[{"address1": "9000 Virginia Manor Road", "address2": "Suite 200", "city": "Beltsville", "state": "MD", "zip": "20705", "country": "United States", "phone": "240 399 4900", "website": "https://www.nextcure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Richman MSBA", "age": 63, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 852699, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy  Mayer Ph.D.", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 619306, "exercisedValue": 0, "unexercisedValue": 12677}, {"maxAge": 1, "name": "Dr. Solomon  Langermann Ph.D.", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 629945, "exercisedValue": 0, "unexercisedValue": 7244}, {"maxAge": 1, "name": "Dr. Lieping  Chen M.D., Ph.D.", "age": 67, "title": "Co-Founder & Chairman of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven P. Cobourn CPA", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 313251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin G. Shaw", "age": 49, "title": "Senior VP & General Counsel", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sourav  Kundu Ph.D.", "age": 63, "title": "Senior Vice President of Development & Manufacturing", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sebastien  Maloveste Ph.D.", "title": "Senior Vice President of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Udayan  Guha M.D., Ph.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4682, "open": 0.4542, "dayLow": 0.39, "dayHigh": 0.4681, "regularMarketPreviousClose": 0.4682, "regularMarketOpen": 0.4542, "regularMarketDayLow": 0.39, "regularMarketDayHigh": 0.4681, "payoutRatio": 0.0, "beta": 1.085, "forwardPE": -0.2762238, "volume": 394727, "regularMarketVolume": 394727, "averageVolume": 234665, "averageVolume10days": 173960, "averageDailyVolume10Day": 173960, "bid": 0.3185, "ask": 0.5246, "bidSize": 2, "askSize": 2, "marketCap": 11079829, "fiftyTwoWeekLow": 0.224, "fiftyTwoWeekHigh": 1.82, "fiftyDayAverage": 0.4737, "twoHundredDayAverage": 0.810555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -37114912, "profitMargins": 0.0, "floatShares": 20654758, "sharesOutstanding": 28050200, "sharesShort": 261794, "sharesShortPriorMonth": 317029, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0093, "heldPercentInsiders": 0.08912, "heldPercentInstitutions": 0.48293, "shortRatio": 1.57, "shortPercentOfFloat": 0.0095, "impliedSharesOutstanding": 29184700, "bookValue": 1.994, "priceToBook": 0.1980943, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -49523000, "trailingEps": -21.24, "forwardEps": -1.43, "enterpriseToEbitda": 0.737, "52WeekChange": -0.76347303, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 0.395, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 55860000, "totalCashPerShare": 1.991, "ebitda": -50337000, "totalDebt": 5842000, "quickRatio": 9.784, "currentRatio": 10.261, "debtToEquity": 10.459, "returnOnAssets": -0.36387002, "returnOnEquity": -0.63941, "freeCashflow": -25449250, "operatingCashflow": -41193000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NXTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1557408600000, "postMarketChangePercent": 8.83544, "postMarketPrice": 0.4299, "postMarketChange": 0.0349, "regularMarketChange": -0.07319999, "regularMarketDayRange": "0.39 - 0.4681", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 234665, "fiftyTwoWeekLowChange": 0.171, "fiftyTwoWeekLowChangePercent": 0.76339287, "fiftyTwoWeekRange": "0.224 - 1.82", "fiftyTwoWeekHighChange": -1.4250001, "fiftyTwoWeekHighChangePercent": -0.78296703, "fiftyTwoWeekChangePercent": -76.347305, "earningsTimestamp": 1746129900, "earningsTimestampStart": 1753873140, "earningsTimestampEnd": 1754308800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -21.24, "epsForward": -1.43, "epsCurrentYear": -1.585, "twoHundredDayAverageChangePercent": -0.5126796, "corporateActions": [{"header": "Split", "message": "NXTC is splitting 1:12 effective Jul. 14, 2025", "meta": {"eventType": "SPLIT", "dateEpochMs": 1752465600000, "splitRatio": "1:12"}}], "postMarketTime": 1752277772, "regularMarketTime": 1752264000, "exchange": "NMS", "messageBoardId": "finmb_321460821", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "NextCure, Inc.", "longName": "NextCure, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -15.634341, "regularMarketPrice": 0.395, "priceEpsCurrentYear": -0.24921136, "fiftyDayAverageChange": -0.078699976, "fiftyDayAverageChangePercent": -0.16613886, "twoHundredDayAverageChange": -0.41555497, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "NextCure", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]